The SETD1B-F2-34* cluster was particularly prominent in uterine endometrial carcinomas, where it accounted for 9.1% of the patients, and it was also observed in 6.8% of the colon adenocarcinoma patients. This evidence concerns the gene SETD1B and endometrial carcinoma.